Quarterly report · Q2
7681.TEDINET S100QQRD
Period2022-10-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.7bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥29.8bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.8bn | 2021-10-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥263m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥771m | 2021-10-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥249m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥710m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥824m | 2021-10-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥249m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥824m | 2021-10-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥144m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥437m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥546m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥154m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥573m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥15.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥13.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥16.1bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥9.8bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.9bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥5.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.5bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.6bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.5bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.4bn | at 2021-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥219m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥242m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥742m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥55m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥50m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥34m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥118m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥121m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥111m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥73.31 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.68 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥222.9 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥278.45 | 2021-10-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.49 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥73.09 | 2022-10-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥221.52 | 2021-10-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥277.57 | 2021-10-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 35.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | ¥1m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥205m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥205m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥4m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥362m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥362m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥39m |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥11.1bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥11.1bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥219m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2023-03-31 | ¥11.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2023-03-31 | ¥11.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-10-01 → 2023-03-31 | ¥262m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-03-31 | ¥1m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥199m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥199m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥4m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥332m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥332m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥41m |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥18.2bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥18.2bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥725m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-10-01 → 2022-03-31 | ¥18.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-10-01 → 2022-03-31 | ¥18.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-10-01 → 2022-03-31 | ¥770m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 498
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 665000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.3392 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 147800 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0754 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 89000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0454 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 78700 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0401 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 66000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0337 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 55600 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0284 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 28000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0143 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 28000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0143 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 24000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0122 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 24000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0122 | |
| Number of shares held | CurrentQuarterInstant_No11MajorShareholdersMember | 24000 | |
| Shareholding ratio | CurrentQuarterInstant_No11MajorShareholdersMember | 0.0122 | |
| Number of shares held | CurrentQuarterInstant_No12MajorShareholdersMember | 24000 | |
| Shareholding ratio | CurrentQuarterInstant_No12MajorShareholdersMember | 0.0122 | |
| Number of shares held | CurrentQuarterInstant_No13MajorShareholdersMember | 24000 | |
| Shareholding ratio | CurrentQuarterInstant_No13MajorShareholdersMember | 0.0122 | |
| Number of shares held | CurrentQuarterInstant_No14MajorShareholdersMember | 24000 | |
| Shareholding ratio | CurrentQuarterInstant_No14MajorShareholdersMember | 0.0122 | |
| Number of shares held | CurrentQuarterInstant_No15MajorShareholdersMember | 24000 | |
| Shareholding ratio | CurrentQuarterInstant_No15MajorShareholdersMember | 0.0122 | |
| Number of shares held | CurrentQuarterInstant_jpcrp040300-q2r_E34455-000No16MajorShareholdersMember | 24000 | |
| Shareholding ratio | CurrentQuarterInstant_jpcrp040300-q2r_E34455-000No16MajorShareholdersMember | 0.0122 | |
| Number of shares held | CurrentQuarterInstant_jpcrp040300-q2r_E34455-000No17MajorShareholdersMember | 24000 | |
| Shareholding ratio | CurrentQuarterInstant_jpcrp040300-q2r_E34455-000No17MajorShareholdersMember | 0.0122 | |
| Number of shares held | CurrentQuarterInstant_jpcrp040300-q2r_E34455-000No18MajorShareholdersMember | 24000 | |
| Shareholding ratio | CurrentQuarterInstant_jpcrp040300-q2r_E34455-000No18MajorShareholdersMember | 0.0122 | |
| Number of shares held | CurrentQuarterInstant | 1398100 | |
| Shareholding ratio | CurrentQuarterInstant | 0.7131 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 1959700 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 19597 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 1100 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 1960800 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 19597 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |